Do patients with prolonged infections contribute to the emergence of new SARS-CoV-2 variants? A research team from the Leibniz Institute of Virology (LIV) and the University Medical Center Hamburg-Eppendorf (UKE) has investigated ...
Aug 17, 2022
0
75
Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg ...
Aug 17, 2022
0
33
Researchers at McMaster University have found a class of well-known antiviral drugs could be part of a one-two punch to treat seasonal influenza and prevent a flu pandemic when used in combination with antibody therapies.
Aug 16, 2022
0
26
Following two years of severe restrictions, everyone is eager to be done with the coronavirus pandemic.
Aug 9, 2022
0
5
COVID-19 is anticipated to keep causing regular outbreak waves for the foreseeable future. The recent COVID-19 waves have caused fewer hospitalizations and deaths than the initial ones, which is largely due to the immunity ...
Aug 8, 2022
0
38
SARS-CoV-2 causes a broad range of clinical symptoms, including potentially fatal acute respiratory distress syndrome (ARDS). A study by Kirsty Short at University of Queensland, Queensland, Australia, and colleagues, published ...
Aug 1, 2022
0
51
At West Boca Medical Center, Dr. Cory Harlow sees patients coming into the emergency department with many of the same symptoms they complained of during the early days of COVID in Florida: pneumonia, high fever and shortness ...
Aug 1, 2022
0
31
Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...
Jul 28, 2022
0
3
The antiviral drugs molnupiravir and nirmatrelvir–ritonavir (Paxlovid), when used to treat nonsevere COVID-19, most likely reduce the risk of subsequent progression to hospitalization and death, according to new research ...
Jul 25, 2022
0
7
As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...
Jul 21, 2022
0
7
